Finance
Novo Nordisk CEO looks beyond weight loss to longevity and aesthetics
Image via Fortune
Article Summary
37 words
Novo itself is beginning to generate data suggesting semaglutide may actually affect biological processes linked to aging, not just body weight. This story was reported by Fortune. For more Finance news in Kenya, stay tuned to Masaa.
Continue Reading
Full story on Fortune
🔗 Clicking will take you to fortune.com


